Abstract:Non-homologous end joining (NHEJ) is a principal pathway of DNA double-strand break (DSB) repair in mammalian cells, 1 but is also involved in assembly of antigen receptor genes and telomere maintenance. 2,3Loss of NHEJ function can result in chromosome instability promoting malignant transformation, in particular when other cellular safeguards are compromised.Inherited NHEJ defects underlie radiosensitive severe combined immunodeficiency.NHEJ is initiated by binding of Ku70-Ku80 heterodimers to both ends of a DNA break, followed by recruitment of catalytic subunits of DNAdependent protein kinase (DNA-PKcs) to form juxtaposed DNA-PK holoenzymes which join the ends in a synaptic complex.Cohesive blunt DNA ends can be joined directly by the XFL-XRCC4-DNA ligase IV complex, but in many cases DNA ends contain damaged bases or DNA backbone sugars that require processing before ligation.End processing may involve nucleases such as Artemis, DNA polymerases and polynucleotide kinase among other enzymes. 4,5n Nature Structural & Molecular Biology, Zhang et al. 6 recently reported the discovery of a long noncoding RNA (lncRNA) termed lncRNA in non-homologous end joining (NHEJ) pathway 1 (LINP1), that serves as an RNA scaffold interacting with Ku70-Ku80 and DNA-PKcs, promoting NHEJ repair (Figure 1).LINP1 was identified as overexpressed in triple-negative breast cancers (TNBCs) when compared with other breast cancer subtypes using RNA-seq data from The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia (CCLE).LINP1 knockdown enhanced apoptosis in TNBC cell lines following doxorubicin treatment, a chemotherapy drug for TNBC, while overexpression of LINP1 in an estrogen-receptor positive breast cancer (ER+ BC) cell line with undetectable LINP1 protected these cells from doxorubicin-induced apoptosis.Using RNA pull-down, CHART and RNA-IP assays, Zhang et al. 6 demonstrated that LINP1 interacted with Ku70-Ku80 and DNA-PKcs.Specifically, LINP1 transcript bound to Ku80 via its 5′ region, and to DNA-PKcs via its 3′ region.LINP1 knockdown in TNBC cells resulted in reduced DNA break repair in comet, γ-H2AX foci and NHEJ reporter assays.Conversely, overexpression of LINP1 in ER+ BC cells increased NHEJ activity.Analyses of chromatin-associated NHEJ complexes post-irradiation with LINP1, Ku80 or DNA-PKcs knockdown indicated that recognition of DSBs by Ku70-Ku80 resulted in recruitment of LINP1 and DNA-PKcs, with LINP1 enhancing the Ku80-DNA-PKcs interaction.It will be interesting to determine the protein domains in Ku80 and DNA-PKcs mediating LINP1 interaction, whether LINP1 binding is regulated by or affects post-translational modifications and conformation states of Ku70-Ku80 or DNA-PKcs, and to what extent this impacts on other NHEJ components.EGF signaling was identified as a positive regulator of LINP1 expression.LINP1 levels were correlated with EGFR expression in primary breast cancers and CCLE cell lines.In CCLE cell lines, LINP1 expression was associated with the EGF downstream transcription factors c-Jun and c-Fox (both AP1 transcription factors), suggesting regulation via the RAS-MEK-JNK pathway.Accordingly, EGF treatment induced LINP1 in TNBC cells, but not in ER+ BC cells and LINP1 expression in TNBC cell lines could be repressed with EGFR, MEK and JNK inhibitors.ENCODE ChIP-seq data indicated enrichment of c-Jun or c-Fos at the LINP1

The LINK-A lncRNA interacts with PtdIns(3,4,5)P 3 to hyperactivate AKT and confer resistance to AKT inhibitors

The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer

LINK-A: unveiling its functional role and clinical significance in human tumors

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

Long Non-Coding RNA LINK-A Promotes Glioma Cell Growth and Invasion Via Lactate Dehydrogenase A.

LINK-A Lncrna Functions in the Metastasis of Osteosarcoma by Upregulating HIF1α.

Long Noncoding RNA LINP1 Acts As an Oncogene and Promotes Chemoresistance in Breast Cancer

The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors

ETS-1-activated LINC01016 Over-Expression Promotes Tumor Progression Via Suppression of RFFL-mediated DHX9 Ubiquitination Degradation in Breast Cancers

Long Noncoding RNA LINP1 Regulates Repair of DNA Double-Strand Breaks in Triple-Negative Breast Cancer

Long Noncoding RNA Linc02023 Regulates PTEN Stability and Suppresses Tumorigenesis of Colorectal Cancer in a PTEN-dependent Pathway.

A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagy

Long Noncoding RNA LINP1: Scaffolding Non-Homologous End Joining

Linc01638 promotes tumorigenesis in HER2+ breast cancer.

LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets

A Novel Lncrna N384546 Promotes Thyroid Papillary Cancer Progression and Metastasis by Acting As a Competing Endogenous RNA of Mir-145-5p to Regulate AKT3

Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma

Clinical Implications of Lncrna LINC-PINT in Cancer

LINC02381 aggravates breast cancer through the miR‐1271‐5p/FN1 axis to activate PI3K/AKT pathway

LINC00152: Potential Driver Oncogene in Pan‐cancer

LincK Contributes to Breast Tumorigenesis by Promoting Proliferation and Epithelial-to-mesenchymal Transition